Innerer Wert von S&P & Nasdaq Kontaktieren

Allied Corp. ALID OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
17/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Allied Corp. (ALID) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - Specialty & Generic Branche. Der Hauptsitz des Unternehmens ist in Kelowna, BC, Canada. Der aktuelle CEO ist Paul Bullock.

ALID hat IPO-Datum 2019-08-15, 150 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $57.75K.

Über Allied Corp.

Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp-derived natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummy under the Tactical Relief brand. The company also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post-activity rub for aches and pains; and Quick Hit, a CBD gummy with vitamin B12 under the Equilibrium Bio brand. In addition, it offers Skin Structure, a facial formula topically applied to enhance skin's radiance and youthfulness; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds to be delivered directly to the desired areas of inflammation, pain, and other skin ailments under the MaXXa brand. In addition, it is developing ALID 10 and ALID 11, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.

📍 1405 St. Paul Street, Kelowna, BC V1Y 2E4 📞 877 255 4337
Unternehmensdetails
SektorGesundheitswesen
BrancheDrug Manufacturers - Specialty & Generic
LandCanada
BörseOther OTC
WährungUSD
IPO-Datum2019-08-15
CEOPaul Bullock
Mitarbeiter150
Handelsinformationen
Aktueller Kurs$0.00
Marktkapitalisierung$57.75K
52-Wochen-Spanne0.0005-0.02555
Beta-0.83
ETFNein
ADRNein
CUSIP019114107
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden